share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tatsis Ourania

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tatsis Ourania

福泰製藥 | 4：持股變動聲明-高管 Tatsis Ourania
美股sec公告 ·  06/04 04:12
牛牛AI助理已提取核心訊息
Ourania Tatsis, EVP, Chief Regulatory & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate occasions. On May 30, 2024, Tatsis sold 2,350 shares of common stock at a price of $439.11 per share. The following day, on May 31, 2024, an additional 2,250 shares were sold at $445.00 per share. The total number of shares disposed of across both transactions was 4,600, resulting in a combined market value of $2,033,158.50. After these transactions, Tatsis directly holds 51,273 shares of Vertex Pharmaceuticals.
Ourania Tatsis, EVP, Chief Regulatory & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate occasions. On May 30, 2024, Tatsis sold 2,350 shares of common stock at a price of $439.11 per share. The following day, on May 31, 2024, an additional 2,250 shares were sold at $445.00 per share. The total number of shares disposed of across both transactions was 4,600, resulting in a combined market value of $2,033,158.50. After these transactions, Tatsis directly holds 51,273 shares of Vertex Pharmaceuticals.
福泰製藥的執行副總裁、首席監管及品質官 Ourania Tatsis（VRTX）於兩個不同的場合完成了公司股份的出售。 2024年5月30日，Tatsis以每股439.11美元的價格出售了2,350股普通股。翌日，即2024年5月31日，又以每股445.00美元的價格出售了2,250股。 兩筆交易中出售的股份數量總共為4,600股，合共市值為2,033,158.50美元。 這些交易之後，Tatsis擁有福泰製藥的51,273股股份。
福泰製藥的執行副總裁、首席監管及品質官 Ourania Tatsis（VRTX）於兩個不同的場合完成了公司股份的出售。 2024年5月30日，Tatsis以每股439.11美元的價格出售了2,350股普通股。翌日，即2024年5月31日，又以每股445.00美元的價格出售了2,250股。 兩筆交易中出售的股份數量總共為4,600股，合共市值為2,033,158.50美元。 這些交易之後，Tatsis擁有福泰製藥的51,273股股份。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。